GLP-1 Agonist Medications: Hype or Revolutionary [impact acv keto gummies]

GLP-1 Agonist Medications: Hype or Revolutionary [impact acv keto gummies]

| 1h 28m 28s | Video has closed captioning.

Dr. Tyler Amell, Chief Health and Strategy Officer at MediKeeper discusses GLP-1 agonist medications, which are used to treat persons with Obesity and Type 2 Diabetes. This session will demystify the medications and help you make informed decisions about well-being programming and overall health benefit strategy. This interactive session focuses on the following: • What are GLP-1 agonists and how do they work? • Is there a role that GLP-1 agonists can play in your wellness programming? • Is there any downside to including these medications in your overall health strategy?